The McGill node will receive funding for 3 years from FRQNT (Fonds de recherche du Québec - Nature et technologies) to conduct a bilateral project together with the Verhelst lab at the KU Leuven in Belgium to develop innovative cleavable linkers for MS-based elucidation of drug binding sites.